Search results for: 'research area metabolism hmg coa reductase'
-
BA3271 WJ-39Summary: WJ-39 is an aldose reductase inhibitor with oral activity. - BA7791 SPL-334Summary: SPL-334 is a potent and selective S-nitrosoglutathione reductase inhibitor.
- BA2898 LCS3Summary: LCS3 is a reversible and non-competitive inhibitor of glutathione disulfide reductase and thioredoxin reductase 1 (3.3 μM and 3.8 μM, respectively).
- BA3416 DopamineSummary: Dopamine is a catecholamine neurotransmitter produced in the substantia nigra, ventral tegmental area of the brain, and hypothalamus that plays an important role in the brain and body.
-
L1042 DiscoveryProbe™ Immunology/Inflammation Compound LibrarySummary: A unique collection of 295 small molecule compounds for immunology/inflammation research. -
L1047 DiscoveryProbe™ Angiogenesis LibrarySummary: A unique collection of 84 small molecule compounds for angiogenesis research. -
B8049 N1-Methylpseudo-UTPSummary: N1-Methyl-Pseudouridine-5'-Triphosphate, a modified nucleoside triphosphate for research on RNA translation and stability - L1042P DiscoveryProbe™ Immunology/Inflammation Compound Library PlusSummary: A unique collection of 806 small molecule compounds for immunology/inflammation research.
- BA4983 TivanisiranSummary: Tivanisiran (SYL1001) is an siRNA that can be used in dry eye research.
- BA9236 SLU-PP-1072Summary: SLU-PP-1072 is a dual inverse agonist for prostate cancer (PCa) research.